Tweet
<img alt="" height="1" width="1" />
FDA denies approval of Amylin, Lilly diabetes drug
Reuters
March 15 (Reuters) - Amylin Pharmaceuticals Inc (AMLN.O) and Eli Lilly and Co (LLY.N) said the US health regulator did not approve a once-weekly form of their diabetes drug Byetta and asked for clarification on the drug's manufacturing process. ...
FDA wants label information on diabetes injectionMarketWatch
FDA finds flaws at Amylin plantCincinnati Business Courier
Amylin Pharma, Eli Lilly And Alkermes Get Complete Response Letter From FDA ...RTT News
Seeking Alpha (blog) -PR Newswire (press release) -Financial News USA (press release)
all 31 news articles »
More...